glp 1 drugs and uti Semaglutide UTI: does GLP-1 therapy increase urinary tract infection risk? Long-term Success of GLP-1s Hinges
Description
A bottom-up approach was used to estimate and validate the total size of the GLP-1 Agonists market

10,11 Regarding IOP-lowering mechanisms, GLP-1RAs have been shown to inhibit sodium-potassium ATPase in the choroid plexus, decreasing cerebrospinal fluid secretion and lowering intracranial pressure

Current evidence is limited because clinical trials excluded breastfeeding mothers
Observational studies at higher risk of bias also show low event rates for thyroid cancer, with effect estimates that are inconsistent among different studies

Still, 512% of participants discontinued the drug, and the rate was higher at maximum doses

While taking CONTRAVE, you or your family members should pay close attention to any changes, especially sudden changes, in mood, behaviors, thoughts, or feelings